¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us

X Facebook

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2025

6.2

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2025

9.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2025

1.446

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2025

1.378

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more

Time to first decision

8 days

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Cover Vol. 30. Issue S2.

Vol. 30. Issue S2.

Abstracts of the 2025 Annual Meeting of the ALEH

(September 2025)

Abstracts of the 2025 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Ann Hepatol. 2025;30 Supl 2: 101947

Full text access

Share

EDITORIAL BOARD

Ann Hepatol. 2025;30 Supl 2: 102125

Full text access

Share

DRUG-INDUCED DUCTOPENIA IN THE SPANISH AND LATINDILI REGISTRIES

Fernando Bessone, Nelia Hernandez, Maria Isabel Schinoni, Javier Brahm, Inmaculada Medina-Caliz, Daniela Chiodi, Mercedes Robles-Díaz, Ismael Alvarez-Alvarez, ... Raul Jesus Andrade

Ann Hepatol. 2025;30 Supl 2: 101948

Full text access

Share

VALIDATION OF NONINVASIVE CLINICAL PATHWAYS TO IDENTIFY ADVANCED

Luis Antonio Díaz Piga, Natalia Baeza, Francisco Idalsoaga, Xiao-Dong Zhou, Ming-Hua Zheng, Fátima Higuera de la Tijera, Fernando Javier Barreyro, Rakhi Maiwall, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2: 101949

Full text access

Share

CHOLANGIOCARCINOMA IN INDIVIDUALS WITH CHRONIC LIVER DISEASE IS DIAGNOSED EARLIER, LEADING TO BETTER PROGNOSIS

Laura Izquierdo Sanchez, Julen Matin Robles, Jone Narbaiza, Angela Lamarca, Adelaida La Casta, Heinz-Josef Klümpen, Arun Valsan, Stephanie Roessler, ... Jesus M. Banales

Ann Hepatol. 2025;30 Supl 2: 101950

Full text access

Share

PERFORMANCE OF NON-INVASIVE TESTS (NITS) AND PREDICTORS OF OUTCOMES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) FROM LATIN AMERICA AND NORTH AMERICA

Zobair Younossi, Leyla de Avila, Claudia P. Oliveira, Cristiane Villela-Nogueira, Marlen Ivon Castellanos Fernandez, Adrian Carlos Gadano, Marco Antonio Arrese Jimenez, Naim Alkhouri, ... Mário Guimaraes Pessôa

Ann Hepatol. 2025;30 Supl 2: 101951

Full text access

Share

ACCELERATED PROGRESSION TO CIRRHOSIS AND HEPATIC DECOMPENSATION IN METALD AND ALD COMPARED TO MASLD: A GLOBAL STUDY

Luis Antonio Díaz Piga, Xiao-Dong Zhou, Natalia Baeza, Francisco Idalsoaga, Gustavo Ayares, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2: 101952

Full text access

Share

FACTORS ASSOCIATED WITH HEALTH LITERACY IN PATIENTS DIAGNOSED WITH LIVER CIRRHOSIS IN COLOMBIA

Ismael de Jesus Yepes Barreto, Carlos Martelo, Nicole Chamorro

Ann Hepatol. 2025;30 Supl 2: 101953

Full text access

Share

MELD 3.0 PERFORMANCE: EXTERNAL VALIDATION IN A LATIN AMERICAN TRANSPLANT LIVER COHORT

Josefina Pages Maronese, Federico Piñero, Graciela Castro Narro, Yahvé Iván López Méndez, Ignacio Roca, Nicolas Dominguez, Fernando Cairo, Angelo Z. Mattos, ... Manuel Mendizabal

Ann Hepatol. 2025;30 Supl 2: 101954

Full text access

Share

HEPATITIS C SCREENING AND GENDER DISPARITIES IN POSITIVITY RATES IN ARGENTINA

Manuel Barbero, Ignacio Roca, Nicolas Dominguez, Lucia Navarro, Omar Galdame, Fernando Cairo

Ann Hepatol. 2025;30 Supl 2: 101955

Full text access

Share

TEMPORAL TRENDS IN CHARACTERISTICS AND OUTCOMES OF SIMULTANEOUS LIVER–KIDNEY TRANSPLANT RECIPIENTS IN LATIN AMERICA FROM 2003 TO 2025

Jorge Carlos Martinez Morales, Valeria Descalzi, Adrián Gadano, Graciela Elia Castro Narro, Mario Vilatobá, Alina Zerega, Fernando Cairo, Manuel Mendizabal, ... Sebastián Marciano

Ann Hepatol. 2025;30 Supl 2: 101956

Full text access

Share

EVIDENCE-BASED DIGITAL SUPPORT IN HEPATOLOGY: RETRIEVAL-AUGMENTED GENERATION'S ROLE IN AUTOIMMUNE LIVER DISEASES MANAGEMENT

Ezequiel Ridruejo, Ernesto Saenz, Jimmy Daza, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bommel, Andreas Geier, ... Andreas Teufel

Ann Hepatol. 2025;30 Supl 2: 101957

Full text access

Share

EFFECTIVE RE-ENGAGEMENT OF HEPATITIS C PATIENTS: A MULTICENTER STUDY BASED ON LABORATORY RECORDS IN ARGENTINA

Fernando Cairo, Manuel Barbero, Nicolas Dominguez, Stefania Burgos, Lucia Navarro, Ignacio Roca, Adrian Bologna, Daniel Calfunao, ... Esteban Gonzalez Ballerga

Ann Hepatol. 2025;30 Supl 2: 101958

Full text access

Share

LATIN AMERICAN SURVEILLANCE REGISTRY REVEALS HIGHER ANTIMICROBIAL RESISTANCE IN INVASIVE ISOLATES FROM PATIENTS WITH CIRRHOSIS COMPARED TO EUROPEAN BENCHMARKS

Gonzalo Gomez Perdiguero, Maria Dolores Murga, Ana Palazzo, Esteban Gonzalez Ballerga, Ilse Pardo Ivirico, Maria Daniela Perez, Lorena Notari, Josefina Pages, ... Sebastian Marciano

Ann Hepatol. 2025;30 Supl 2: 101959

Full text access

Share

BRIDGING THE GAP IN HCC CARE: FIRST REAL-WORLD ANALYSIS OF BCLC ADHERENCE AND SURVIVAL IN A CENTRAL AMERICAN POPULATION

Wagner Ramirez Quesada, María Fernanda Lynch Mejía, Francisco Vargas Navarro, María José Soto Echeverri, Fiorella Ajún, Alejandra Ochoa Palominos, Pablo Coste

Ann Hepatol. 2025;30 Supl 2: 101960

Full text access

Share

ABO - INCOMPATIBLE LIVER TRANSPLANTATION FROM DECEASED DONORS: A PROMISING ALTERNATIVE FOR LATIN AMERICA IN LOW ORGAN DONATION SCENARIOS

María Fernanda Lynch Mejía, Wagner Ramírez Quesada, Francisco Vargas Navarro, Sheila Araya Chavarría, Alejandra Ochoa Palominos, Pablo Coste Murillo

Ann Hepatol. 2025;30 Supl 2: 101961

Full text access

Share

TRANSFORMING OUTPATIENT HEPATIC CARE IN LATIN AMERICA: A SCALABLE, NURSE-DRIVEN APPROACH

Francisco Vargas-Navarro, Maria Soto-Echeverri, Daniel Mondragón-Bustos, Wagner Ramírez-Quesada, Maria Lynch-Mejía, Roy Quesada-Mora, Alejandra Ochoa-Palominos, Pablo Coste

Ann Hepatol. 2025;30 Supl 2: 101962

Full text access

Share

CRITICAL MEDIATORS OF INFLAMMATION-DRIVEN HEPATOCARCINOGENESIS INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

Linda Vanessa Márquez Quiroga, Eduardo E. Vargas Pozada, Irina Cardoso Lezama, Carolina Piña Vázquez, Jaime Arellanes Robledo, Pablo Muriel de la Torre

Ann Hepatol. 2025;30 Supl 2: 101963

Full text access

Share

EARLY IDENTIFICATION OF LIVER TRANSPLANTATION REQUIREMENT IN ALCOHOL-ASSOCIATED HEPATITIS

Luis Antonio Díaz Piga, Francisco Idalsoaga, Gene Im, Bastián Alcayaga, Muzzafar Haque, Stephanie Rutledge, Hanna Blaney, Pojsakorn Danpanichkul, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2: 101964

Full text access

Share

LONG-TERM ALBUMIN THERAPY MAY IMPROVE SURVIVAL IN CIRRHOSIS WITH ASCITES: A SYSTEMATIC REVIEW AND META-ANALYSIS

W. Ray Kim, Guadalupe Garcia-Tsao, Cristina Coll-Ortega, Elisabet Viayna, Thomas Ardiles, Rahul Rajkumar

Ann Hepatol. 2025;30 Supl 2: 101965

Full text access

Share

LIVER FIBROSIS IN INDIVIDUALS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN LATIN AMERICA: INTERIM RESULTS FROM THE STELLA STUDY

Luis Antonio Díaz Piga, Francisco Idalsoaga, Mario G. Pessoa, Claudia Pinto Marques Souza de Oliveira, Patricia Zitelli, Ezequiel Ridruejo, Mirta Peralta, Cesar Castro, ... Marco Arrese

Ann Hepatol. 2025;30 Supl 2: 101966

Full text access

Share

SOCIAL AND HEALTH VULNERABILITY ANALYSIS AMONG PEOPLE WHO INJECT DRUGS IN ARMENIA, COLOMBIA

Javier Enrique Hernandez Blanco, Juan Ignacio Marin Zuluaga, Ismael de Jesús Yepes Barreto, Diana Chávez Bejarano, Alfredo Spath, Sara Milena Ramos Jaraba, Dedsy Yajaira Berbesí Fernández

Ann Hepatol. 2025;30 Supl 2: 101967

Full text access

Share

REVIRAL: ROADMAP FOR THE ELIMINATION OF VIRAL HEPATITIS IN LATIN AMERICA

Javier Crespo, Joaquin Cabezas Gonzalez, Graciela Castro Narro, Hugo Cheinquer, Fernando Contreras, Nelia Hernández, Christie Perelló, Ezequiel Ridruejo, ... José Luís Calleja

Ann Hepatol. 2025;30 Supl 2: 101968

Full text access

Share

VALIDATION OF AGILE-3+ AND AGILE-4 SCORES FOR NONINVASIVE DETECTION OF FIBROSIS AND CIRRHOSIS IN METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE IN LATIN AMERICA

Carlos Esteban Coronel Castillo, Luis Antonio Díaz Piga, Natalia Baeza, Francisco Idalsoaga, Daniel Cabrera Garcia, Fernando Javier Barreyro, Sebastian Marciano, Jorge Martinez Morales, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2: 101969

Full text access

Share

EXPLORING THE ROLE OF METABOLIC DYSFUNCTION IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL STUDY

María Ignacia Pérez Garayar, Vania Cari Gormaz, Ignacio Téllez, Francisco Idalsoaga, Gene Im, Bastian Alcayaga, Muzzafar Haque, Stephanie Rutledge, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2: 101970

Full text access

Share

CHARACTERIZATION OF THE UNRECORDED ALCOHOL USE WORLDWIDE: A SYSTEMATIC REVIEW AND SURVEY-BASED STUDY

Katherine Emilia Maldonado Cardona, Hanna Blaney, Deepika Devuni, Muzzafar Haque, Pojsakorn Danpanichkul, Francisco Idalsoaga, Vinay Jahagirdar, Kaanthi Rama, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2: 101971

Full text access

Share

IDENTIFICATION OF NOVEL INTESTINAL MICROBIOTA-BASED MARKERS ASSOCIATED WITH DYSBIOSIS, SEPSIS AND SHORT-TERM MORTALITY IN ALCOHOL-RELATED DECOMPENSATED CIRRHOSIS AND ACUTE-ON-CHRONIC LIVER FAILURE

María Daniela Sánchez Gutiérrez, Paula Alejandra Castaño Jimenéz, Luis Gilberto Huerta Gómez, Marina Campos Valdez, Miriam Ruth Bueno Topete, Tonatiuh Abimael Baltazar Díaz

Ann Hepatol. 2025;30 Supl 2: 101972

Full text access

Share

EFFECTS OF MELATONIN AND PHYSICAL EXERCISE ON SECONDARY BILIARY CIRRHOSIS

Marilda da Silva Brasil, Elizângela Gonçalves Schemitt, Sandielly Rebeca Benitez da Fonseca, Gabriela dos Santos Martins, Millena de Oliveira Engeroff, Giorgia Assoni, Lorenzo Cercal Britto, Cláudio Augusto Marroni, Norma Possa Marroni

Ann Hepatol. 2025;30 Supl 2: 101973

Full text access

Share

ARTIFICIAL INTELLIGENCE FOR SURVIVAL PREDICTION IN HEPATOCELLULAR CARCINOMA: DEVELOPMENT AND VALIDATION OF A CLINICAL DATA–DRIVEN MODEL IN A COHORT OF 129 PATIENTS

Giovane Carvalho Viola, Rodolfo Viola, Renato Altikes, Claudia Tani, Flair Carrilho, Lisa Saud, Mário Pessoa, Aline Chagas, ... Claudia Oliveira

Ann Hepatol. 2025;30 Supl 2: 101974

Full text access

Share

AUTOIMMUNE HEPATITIS IN LATIN AMERICA: INSIGHTS FROM THE ALLATIN COHORT

Ludmila Resende Guedes, Guilherme Grossi Lopes Cançado, Janaína Luz Narciso Schiavo, Luciana Costa Faria, Ezequiel Ridruejo, Maria Lucia Ferraz, Margarita Anders, Lorena Castro Solari, ... Cláudia Alves Couto

Ann Hepatol. 2025;30 Supl 2: 101975

Full text access

Share

PROTECTIVE ROLE OF MTARC1 RS2642438 POLYMORPHISM AGAINST FIBROSIS PROGRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

Sofia Rocha, Claudia Oliveira Marques, Jose Tadeu Stefano, Raymundo Soares Azevedo, Michele Soares Gouvea, Patricia Momoyo Zitelli, Mario Guimaraes Pessoa, Joao Renato Rebello Pinho

Ann Hepatol. 2025;30 Supl 2: 101976

Full text access

Share

INFLUENCE OF GLYCEMIC CONTROL ON THE SEVERITY OF HEPATIC STEATOLOGY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Yenni Joseline Cruz Ramírez, Reyna Sarai Velez Ramirez, Luis Erick Cardona Rodriguez, Mayra Virginia Ramos Gómez

Ann Hepatol. 2025;30 Supl 2: 101977

Full text access

Share

BIOACTIVE COFFEE COMPOUNDS SYNERGISTICALLY ENHANCE THE ANTITUMOR EFFECTS OF CHEMO AND IMMUNOTHERAPY FOR HEPATOCELLULAR CARCINOMA IN VITRO

Leticia Valente Cardoso, Luana Casarin Riechelmann, Luis Barbisan Fernando, Guilherme Romualdo Ribeiro

Ann Hepatol. 2025;30 Supl 2: 101978

Full text access

Share

INFLUENCE OF CARDIOMETABOLIC RISK FACTORS AND ALCOHOL CONSUMPTION ON LIVER STIFFNESS IN PATIENTS WITH MASLD: A MULTICENTER STUDY IN COLOMBIA

Ismael de Jesus Yepes Barreto, Nicole Chamorro, Guillermo Donado, Pablo Osorio, Juan Carlos Restrepo, Santiago Pino, Clara Caez, Jorge Ortiz, Yohana Poveda

Ann Hepatol. 2025;30 Supl 2: 101979

Full text access

Share

HEALTH LITERACY AS A DETERMINANT OF FRAILTY IN PATIENTS WITH LIVER CIRRHOSIS

Ismael de Jesús Yepes Barreto, Nicole Chamorro, Guillermo Donado

Ann Hepatol. 2025;30 Supl 2: 101980

Full text access

Share

PREVALENCE OF LIVER FIBROSIS IN RELATIVES OF PATIENTS WITH MASLD-RELATED CIRRHOSIS: A STUDY ON DEGREE OF KINSHIP

Ismael de Jesús Yepes Barreto, Nicole Chamorro, Guillermo Donado

Ann Hepatol. 2025;30 Supl 2: 101981

Full text access

Share

RELATIONSHIP BETWEEN QUALITY OF LIFE AND AN EDUCATIONAL STRATEGY BASED ON THE INFORMATION NEEDS OF PATIENTS WITH COMPENSATED LIVER CIRRHOSIS

Ismael de Jesús Yepes Barreto, Yohana Poveda, Guillermo Donado

Ann Hepatol. 2025;30 Supl 2: 101982

Full text access

Share

THE RELATIONSHIP BETWEEN QUALITY OF LIFE IN ADULT SUBJECTS WITH COMPENSATED LIVER CIRRHOSIS AND BACTERIAL OVERGROWTH

Nicole Chamorro Guzmán, Ismael de Jesús Yepes Barreto, Sindy Yohana Poveda Salinas

Ann Hepatol. 2025;30 Supl 2: 101983

Full text access

Share

IMPROVEMENT OF CARDIOVASCULAR RISK ASSESSMENT ON A COHORT OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

Pedro Miguel Mattos Nogueira, Carlos Eduardo Cruz Marques, Breno Corrêa Vieira, Ana Carolina Cardoso, Natalia Wajbrot, Claudia Equi, Nathalie Carvalho Leite, Glaucia Moraes de Oliveira, Cristiane Villela-Nogueira

Ann Hepatol. 2025;30 Supl 2: 101984

Full text access

Share

CHANGES IN BODY COMPOSITION AND HEPATIC ELASTOGRAPHY VALUES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AT A MEDICAL CENTER IN CARTAGENA – COLOMBIA, DURING THE PERIOD FROM OCTOBER 2023 TO JANUARY 2025

Arturo Jose Viera Oliveros, Ismael Yepes Barreto, Yohana Poveda Salinas, Fernando García del Risco

Ann Hepatol. 2025;30 Supl 2: 101985

Full text access

Share

PLANT-DERIVED MONOTERPENE SYNERGIZES WITH SORAFENIB TO SUPPRESS DRUG-TRIGGERED HEPATOCELLULAR CARCINOMA IN ANIMALS

Amr Amin

Ann Hepatol. 2025;30 Supl 2: 101986

Full text access

Share

CONNECTIVE TISSUE GROWTH FACTOR AS A MARKER OF FIBROSIS IN PATIENTS WITH CHOLESTASIS

Jessica Mejía Ramírez, Fatima Higuerade la Tijera, Carolina Guzman, Ángel Daniel Santana Vargas, Viridiana López Ladron de Guevara, Cristian Yamin Sánchez Sánchez, Diego Fernando Abendaño Rivera, Maria Argentina Díaz Castro, ... Jose Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2: 101987

Full text access

Share

CONNECTIVE TISSUE GROWTH FACTOR ASSESSMENT: DETERMINATION OF CUT-OFF POINTS FOR LIVER FIBROSIS IN CHOLESTASIS

Jessica Mejía Ramírez, Fatima Higuera de la Tijera, Carolina Guzman, Ángel Daniel Santana Vargas, Viridiana López Ladron de Guevara, Cristian Yamin Sánchez Sánchez, Diego Fernando Abendaño Rivera, Maria Argentina Díaz Castro, ... Jose Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2: 101988

Full text access

Share

EVALUATION OF RESPONSE TO SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO UDCA: A PILOT STUDY OF LIVER BIOPSIES FOLLOW UP

Alejandra Villamil, Daniela de la Viña, Eduardo Mullen, Ignacio Lucero, Juan Carlos Bandi

Ann Hepatol. 2025;30 Supl 2: 101989

Full text access

Share

CORE MUTATIONS IN THE HBEAG-NEGATIVE STAGE ARE KEY DETERMINANTS OF HEPATITIS B VIRUS REPLICATION

Selene Leuzzi, Cecilia Garcia, Diego Flichman, Maria Mercedes Elizalde

Ann Hepatol. 2025;30 Supl 2: 101990

Full text access

Share

METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE-RELATED SIGNIFICANT AND ADVANCED FIBROSIS' PREVALENCE IN BRAZIL AND THE ASSOCIATED ACCURACY OF FIB-4 AND VIBRATION-CONTROLLED ELASTOGRAPHY - A NATIONAL REGISTER

Cristiane Alves Villela-Nogueira, Cristiane Valle Tovo, Nathalie Carvalho Leite, Mário Reis Álvares-da-Silva, Claudia Alexandra Ivantes, Claudia Alves Couto, Giovanni Faria Silva, Edson Roberto Parise, ... Claudia P.M.S. Oliveira

Ann Hepatol. 2025;30 Supl 2: 101991

Full text access

Share

DURATION OF TYPE 2 DIABETES AS A CLINICAL PREDICTOR OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE

Daniza Alexandra Contreras de los Santos, Invis Perez Mendez, Omar Ebrahim Ibrahim

Ann Hepatol. 2025;30 Supl 2: 101992

Full text access

Share

FULL COMPLIANCE TO QUALITY INDICATORS IN ACUTE VARICEAL BLEEDING REDUCES 6-WEEK MORTALITY.

Edgar Suarez, Juan Carlos Montaño, Ezequiel Demirdjian, Diego Arufe

Ann Hepatol. 2025;30 Supl 2: 101993

Full text access

Share

BLOOD MICROBIOTA ASSESSED BY NEXT-GENERATION SEQUENCING AND SYSTEMIC INFLAMMATION MARKERS IN ACUTE-ON-CHRONIC LIVER FAILURE: PILOT REPRESENTATIVE STUDY FROM WESTERN MEXICO

Paula Alejandra Castaño Jimenez, Tonatiuh Abimael Baltazar Díaz, Luis Gilberto Huerta Gómez, Ksenia Klimov Kravtchenko, Susana del Toro Arreola, Jesse Haramati, Luz Alicia González Hernández, Miriam Ruth Bueno Topete

Ann Hepatol. 2025;30 Supl 2: 101994

Full text access

Share

ARTIFICIAL INTELLIGENCE IN PREDICTING THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH METABOLICALLY ASSOCIATED STEATOTIC LIVER DISEASE: DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL IN 306 PATIENTS

Giovane Carvalho Viola, Rodolfo Carvalho Viola, Regiane Alencar, Renato Altikes, Claudia Tani, Lisa Saud, Mario Pessoa, Aline Chagas, Claudia Oliveira

Ann Hepatol. 2025;30 Supl 2: 101995

Full text access

Share

Publish in

Annals of Hepatology

Affiliated societies

asdasdasd